Lexaria Bioscience Corp.: Lexaria Awards Contract For Third GLP-1 Human Pilot Study

First-ever DehydraTECH-processed tirzepatide from Zepbound® to be tested in a swallowed oral formatKELOWNA, BC / ACCESSWIRE / May 23, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company"

Related Keywords

George Jurcic ,Chris Bunka ,Eli Lilly ,Nasdaq ,Exchange Commission ,Lexaria Bioscience Corp ,Company Or Lexaria ,Drug Administration ,Lexaria Bioscience ,Review Board ,Ihr Portfolio ,